Nautilus Biotechnology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -13.8% | -13.8% | -12.6% |
| FY2022 | -18.4% | -18.4% | -16.5% |
| FY2023 | -24.0% | -24.0% | -20.8% |
| FY2024 | -33.9% | -33.9% | -29.2% |
| FY2025 | -37.6% | -37.6% | -30.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -13.8% | -13.8% | -12.6% |
| FY2022 | -18.4% | -18.4% | -16.5% |
| FY2023 | -24.0% | -24.0% | -20.8% |
| FY2024 | -33.9% | -33.9% | -29.2% |
| FY2025 | -37.6% | -37.6% | -30.9% |